Filter
1376
Text search:
cost-effectiveness
Featured
125
354
Language
Document type
715
253
220
81
64
18
18
2
2
1
1
Countries
75
48
43
39
34
30
28
26
21
18
17
17
16
16
15
15
14
14
12
11
10
10
9
9
8
8
8
8
8
7
7
7
7
7
6
6
5
5
5
5
5
5
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
398
180
112
76
70
16
15
Toolboxes
169
118
59
50
49
45
44
42
42
38
35
32
26
22
17
17
17
17
13
11
9
7
7
2
1
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
Research
BMJ 2014;349:g4643 doi: 10.1136/bmj.g4643 (Published 5 August 2014), 1-11
Update 2021; Immunization, Vaccines and Biologicals
Eur Respir J 2014; 43: 24–35 | DOI: 10.1183/09031936.00113413
Int J Vaccines Vaccin 2016, 2(1): 00018, January 29, 2016
Offical Statement
INT J TUBERC LUNG DIS 12(12):1376–1379
Review
Triccas and Counoupas Pneumonia (2016) 8:18; DOI 10.1186/s41479-016-0020-z
Guidance on TB and TB/HIV prevention, diagnosis, treatment and care in the workplace
17–24 November 2015
Weekly epidemiological record/ Relevé épidémiologique hebdomadaire 4 AUGUST 2017, 92th YEAR / 4 AOÛT 2017, 417-436
Eur Respir J. 2014 April ; 43(4): 1132–1141. doi:10.1183/09031936.00203613.
14–22 April 2015
Recommendations for Tuberculosis Screening Before Initiation of TNF-α-Inhibitor Treatment in Rheumatic Diseases
Diel R et al. Empfehlungen für das Tuberkulosescreening vor Gabe von TNF-α-Inhibitoren… Pneumologie 2009; 63: 329–334
DHS Analytical Studies No. 39